Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamidronate for bone loss prevention in renal transplant
NCT00738257Phase 4Completed
- Sponsor
- Novartis
- Start
- Jun 2000
- Primary completion
- Dec 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of pamidronate in osteoporosis, sponsored by Novartis. Started Jun 2000; status: completed.
02
Drugs
pamidronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00738257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00738257.